1.
Sinopharm Vaccine, SARS-CoV-2 breakthrough infections and Hemoglobinopathies. Mediterr J Hematol Infect Dis [Internet]. 2022 Jun. 29 [cited 2026 Jun. 19];14(1):e2022060. Available from: https://www.mjhid.org/mjhid/article/view/5021